Insights: Publications Would Repurposing Minocycline Alleviate Neurologic Manifestations of COVID-19?
Frontiers in Neuroscience, Volume 14
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the etiologic agent of COVID-19 pandemic (Zhu et al., 2020). SARS-CoV-2 causes systemic infection varying in severity from asymptomatic, to mild (fever, cough, loss of smell and taste, leg pain, headache, diarrhea, fatigue), to multi-organ dysfunction/failure (Chen N. et al., 2020). Acute lung injury is the hallmark of COVID-19 and a subset of patients develop pneumonia and severe dyspnea requiring ICU admission. Most patients in critical condition have advanced age and pre-existing hypertension, cardiovascular disease (CVD), diabetes, obesity, and/or chronic lung conditions (Chen N. et al., 2020; Sharma et al., 2020b). Dyspnea and saturation of 90% or less despite oxygen supplementation is a major risk factor for fatal outcomes (Xie et al., 2020).
Related People
Related Industries
Disclaimer
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.
